Clinical Decision Support Systems Market

Clinical Decision Support Systems Market by Component (Services, Software), Delivery Mode, Product, Application, Model (Knowledge-based), Type (Therapeutic, Diagnostic), Interactivity (Active, Passive), Patient Care Setting - Global Forecasts to 2023

Report Code: HIT 2237 Mar, 2018, by marketsandmarkets.com

The global clinical decision support systems market is projected to reach USD 1,752.0 million by 2023 from an estimated USD 1,001.9 million in 2018, growing at a CAGR of 11.8%. This growth can be attributed to factors such as government support & initiatives, growing incidence of medication errors; rising prominence & usage of big data and mhealth tools, high returns on investment for CDSS solutions, and growing adoption of cloud computing in healthcare are driving the growth of this market.

Clinical Decision Support Systems Market by region, 2023

By delivery mode, cloud-based segment is expected to grow at the highest rate during the forecast period

Based on delivery mode, the clinical decision support systems market is segmented into on-premise and cloud-based mode. The cloud-based segment is estimated to witness the highest CAGR during 2018–2023. The high growth can be attributed to the flexibility and scalability offered by these solutions.

By application, advanced CDSS segment is expected to grow at the highest rate during the forecast period

By application, the global clinical decision support systems market is broadly segmented into conventional CDSS and advanced CDSS. The advanced CDSS segment is expected to grow at the highest CAGR during 2018–2023. The high growth of the segment can be attributed to factors such as healthcare organizations attempting to upgrade CDSS systems which perform functions such as population health management, treatment planning, protocol validation, and health economics management.

The services segment will continue to dominate the clinical decision support systems component market during the forecast period

By component, the market is segmented into services, software, and hardware. In 2017, the services segment accounted for the largest share of the CDSS market. The large market share of this segment can be attributed to the indispensable and recurring nature of services in supporting the installation, operation, and maintenance of clinical decision support systems.

By product, integrated CDSS accounted for the largest contributor of the CDSS market

By product, the global clinical decision support systems market is broadly segmented into integrated CDSS and standalone CDSS. In 2017, the integrated CDSS segment is accounted for the largest share of the CDSS market. The largest share of this segment can be attributed to factors such as healthcare organizations opting to integrated solutions which comprise several interconnected application programs that share a common database and user interface. These systems provide clinicians and decision-makers with a robust database to support evidence-based clinical decision-making.

By settings, the inpatient settings segment held the largest share of the CDSS market in 2017

By settings, the CDSS market has been categorized into inpatient settings and ambulatory care settings. The inpatient settings segment commanded the largest share of the CDSS market in 2017. The large share of this segment can be attributed to the large volumes of patient data that need to be captured and analyzed in inpatient settings, owing to the increased adoption of integrated healthcare IT modules including clinical decision support solutions.

By model, the knowledge-based CDSS segment accounted for the largest share of CDSS market in 2017

By model, the global clinical decision support systems market is segmented into knowledge-based CDSS and non- knowledge-based CDSS. The knowledge-based CDSS segment accounted for the largest share of CDSS market in 2017. The large share and high growth of this segment can be attributed to the several beneficial functionalities of these systems, such as helping clinicians with knowledge-based reasoning to make clinical decisions in the face of uncertainties. These systems can also be integrated into clinical workflows and are less prone to errors as compared to non-knowledge-based systems.

By level of interactivity, active CDSS segment is the largest contributor of the CDSS market

By level of interactivity, the global clinical decision support systems market is segmented into active CDSS and passive CDSS. In 2017, the active CDSS segment accounted for the largest share of the clinical decision support systems market. The large share of the active CDSS can be attributed to extensive use by healthcare providers, robust government initiatives to promote clinical IT solutions such as EHR, CDSS, and CPOE and the growing pressure to curtail healthcare costs serve to support the growth of this segment.

By type, the therapeutic CDSS segment commanded the largest share of the CDSS market in 2017

By type, the global clinical decision support systems market is categorized into therapeutic CDSS and diagnostic CDSS. The therapeutic CDSS segment commanded the largest share of the CDSS market in 2017. The large share of this segment can be attributed to the extensive adoption by clinicians and caregivers. Therapeutic clinical decision support systems have the ability to transform clinical practices through interactive assistance with therapeutic best practices rather than only offering diagnostic support. Besides, these systems allow clinicians to make informed clinical decisions and support evidence-based medicine but do not limit the autonomy of practitioners.

Clinical Decision Support Systems Market by region, 2023

North America accounted for a significant share in the CDSS market in 2017 while the Asia Pacific region is expected to register the highest growth during the forecast period

Geographically, the North American market accounted for the largest share of the global clinical decision support systems market in 2017. The large share can be attributed to factors such as the rising demand for quality healthcare delivery, need to curb increasing healthcare expenditure, and implementation of favorable initiatives & regulations are driving the growth of the CDSS market in the US. Additionally, the rising incidence of medical errors in the US necessitate the utilization of advanced solutions such as CDSS in healthcare.

Market Dynamics

Driver: Partnerships between medical research groups and clinical decision support companies

In 2017, global digital health funding increased by 42% to USD 7.2 billion, of which CDSS received USD 514 million. Such funding helps CDSS companies and medical research groups to invest and partner to provide new innovative solutions. Such partnerships help develop CDSS tools enabling healthcare providers and their patients to make the best decision based on specific circumstances. For instance, in September 2017, Mayo Clinic (US) partnered with the National Decision Support Company (NDSC) (US) to develop a CDS tool “CareSelect Lab” comprising recommendations for lab test ordering. This tool is an extension of NDSC’s capabilities to deliver EHR-integrated guidelines and brings together the industry standard for EHR-delivered guidance with the more than 1,500 best-practice care models—authored, curated and maintained by Mayo Clinic. In September 2017, Mayo Clinic also partnered with Epic Systems (US) to offer its secure, web-based symptom assessment tool “Ask Mayo Clinic” through “Epic MyChart,” assisting patients in managing their own care. Such partnerships offer potential growth opportunities for market players, which is also likely to drive the adoption of CDSS solutions.

Restraint: Reluctance to adopt mobile CDSS

Stakeholder engagement is the key to success of healthcare IT solutions such as mobile CDSS. If healthcare providers are forced to adopt mobile CDSS by external mandates in the absence of common goals, they may actively resist the technology, misuse it, or otherwise not utilize it in the manner intended by its designers. Thus, the gains realized from technology use are likely to be minimal. The reluctance of providers in terms of adopting mobile CDSS may be due to factors such as confidentiality and safety issues, concerns over reliability and quality of patient data, costs and time constraints, lack of literacy, and legal uncertainties, among others. Cooperation of providers is very important for the implementation of mobile CDSS.

According to a survey conducted in May 2017 by Spok Holdings, Inc., a clinical communication solution provider, 69% of hospitals view mobile strategies as a key initiative to improve clinical and operational health outcomes. However, despite this awareness, nearly 60% of clinical staff do not have mobile access to CDSS.

Providers may also be reluctant due to lack of infrastructure to support these solutions or lack of skill and training to implement the solutions. Moreover, many providers prefer a traditional approach of clinical decision making as opposed to relying on technologically advanced solutions such as mobile CDSS.

Opportunity: Emerging markets for healthcare IT

In Asia and Australasia, the rollout of public healthcare programs combined with growing consumer wealth is anticipated to boost healthcare spending at an average of 8.1% from 2014 to 2018 (Source: The Economist Intelligence Unit). Government initiatives for the implementation of HCIT solutions, rise in government spending on healthcare systems, and increase in the number of skilled IT experts are the major factors favoring the adoption of CDSS in the emerging markets across Asia Pacific.

Below is an indicative list of pointers that showcases the potential of the Asia Pacific CDSS market:

  • The percentage of primary care physicians adopting EMR in Australia (92%) exceeded the adoption rate in the US (84%) (Source: OECD, 2015 International Profiles of Health Care Systems).
  • China’s 13th Five-Year Plan (FYP), initiated in November 2015, focuses on changes in areas of healthcare services. Government healthcare spending in China increased from 15% in 1999 to 30% in 2013, and out-of-pocket spending dropped from 60% to 34%. In China, information technology is leveraged to revolutionize healthcare, drug development, and distribution. The use of mobile health technologies (mHealth) is also increasing in China to improve connectivity with rural/remote areas. Additionally, the “Big Three” Chinese internet and e-commerce companies (Baidu, Alibaba, and Tencent) are also investing in the healthcare industry (Source: China’s Healthcare Sector and U.S.- China Health Cooperation, Council on Foreign Relations).
  • The Indian Government started the “Digital India” campaign in 2015 to ensure that government services are made available to citizens electronically by improving IT infrastructure and improving internet connectivity. These factors are likely to encourage the adoption of CDSS among hospitals in the country.

Growth in healthcare spending in emerging markets such as the Middle East, Africa, and Latin America is also likely to drive the adoption of healthcare IT solutions such as CDSS. Key statistics regarding increased healthcare spending in these regions are mentioned below.

  • Rapid growth in healthcare spending is expected in the Middle East and Africa, with an annual average increase of 8.7% from 2014 to 2018 (Source: The Economist Intelligence Unit, May 2014). This can be attributed to population growth and efforts to increase the quality of care.
  • Healthcare spending in Latin America is projected to increase at an average of 4.6% per annum from 2014 to 2018. Healthcare spending in Brazil has increased in GDP terms, which is majorly due to the rising disposable income and higher public healthcare expenditure. In 2013, Brazil’s total healthcare spending was estimated at 9.1% of the GDP (Source: WHO).

Scope of the report

Report Metric

Details

Market size available for years

2016-2023

Base year considered

2017

Forecast period

2018-202

Forecast units

Value (USD)

Segments covered

Component, Product, Type, Model, Delivery Mode, Application, Level of Interactivity, Setting, and Region

Geographies covered

North America (US & Canada), Europe (Germany, UK, France, & RoE), APAC, and RoW

Companies covered

Wolters Kluwer Health (US), Hearst Health (US), and Elsevier B.V. (Netherlands). Major 10 players covered.

This research report categorizes the CDSS market based on component, product, type, model, delivery mode, application, level of interactivity, setting, and region

On the basis of component, the clinical decision support systems market has been segmented as follows:

  • Hardware
  • Software
  • Services

On the basis of delivery mode, the clinical decision support systems market has been segmented as follows:

  • Cloud-based
  • On-premise

On the basis of product, the clinical decision support systems market has been segmented as follows:

  • Standalone CDSS
  • Integrated CDSS

On the basis of type, the clinical decision support systems market has been segmented as follows:

  • Therapeutic CDSS
  • Diagnostic CDSS

On the basis of model, the clinical decision support systems market has been segmented as follows:

  • Knowledge-based CDSS
  • Non-Knowledge-based CDSS

On the basis of user interactivity, the clinical decision support systems market has been segmented as follows:

  • Active CDSS
  • Passive CDSS

On the basis of application, the clinical decision support systems market has been segmented as follows:

  • Conventional CDSS
  • Advanced CDSS

On the basis of setting, the clinical decision support systems market has been segmented as follows:

  • Inpatient Settings
  • Ambulatory Care Settings

On the basis of region, the clinical decision support systems market has been segmented as follows:

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • RoE
  • Asia Pacific
  • Rest of the World (RoW)

Key Market Players

Wolters Kluwer Health (US), Hearst Health (US), and Elsevier B.V. (Netherlands) are the leading players in the market. Other prominent players include Cerner Corporation (US), McKesson Corporation (US), Epic Systems Corporation (US), MEDITECH (US), Philips Healthcare (Netherlands), International Business Machines (IBM) (US), and Allscripts Healthcare Solutions, Inc. (US).

Recent Developments:

  • In 2018, Elsevier (Netherlands) acquired Via Oncology (US) To expand its solution offerings and presence in the US
  • In March 2016, Philips Healthcare (Netherlands) launched IntelliSpace Console Critical Care a cloud-based clinical decision support system allowing clinicians to access patient data across multiple systems and EMRs

Key questions addressed by the report:

  • Where will all these developments take the industry in the mid to long term?
  • What are the upcoming applications for clinical decision support systems?

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Table of Contents

1 Introduction (Page No. - 17)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered for the Study
    1.4 Currency
    1.5 Limitations
    1.6 Stakeholders

2 Research Methodology (Page No. - 21)
    2.1 Research Data
           2.1.1 Secondary Data
                    2.1.1.1 Secondary Sources
           2.1.2 Primary Data
                    2.1.2.1 Key Data From Primary Sources
                    2.1.2.2 Breakdown of Primaries
                    2.1.2.3 Key Industry Insights
    2.2 Market Size Estimation
    2.3 Market Breakdown and Data Triangulation
    2.4 Assumptions for the Study

3 Executive Summary (Page No. - 30)

4 Premium Insights (Page No. - 37)
    4.1 Clinical Decision Support Systems Market Overview
    4.2 Clinical Decision Support Systems Market, By Model (2018 Vs. 2023)
    4.3 Clinical Decision Support Systems Market, By Level of Interactivity  (2018 Vs. 2023)
    4.4 Clinical Decision Support Systems Market, By Application (2018 Vs. 2023)
    4.5 Geographic Snapshot of the Clinical Decision Support Systems Market

5 Market Overview (Page No. - 41)
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Market Drivers
                    5.2.1.1 Government Support and Initiatives
                    5.2.1.2 High Prevalence of Chronic Diseases
                    5.2.1.3 Growing Incidence of Medication Errors
                    5.2.1.4 Rising Prominence and Usage of Big Data and Mhealth Tools
                    5.2.1.5 High Returns on Investment for CDSS Solutions
                    5.2.1.6 Growing Adoption of Cloud Computing in Healthcare
                    5.2.1.7 Partnerships Between Medical Research Groups and Clinical Decision Support Companies
                    5.2.1.8 Rapid Growth in the Geriatric Population
           5.2.2 Restraints
                    5.2.2.1 Reluctance to Adopt Mobile CDSS
                    5.2.2.2 High Investments for It Infrastructure
                    5.2.2.3 Data Security Concerns Related to Cloud-Based CDSS
                    5.2.2.4 Lack of Interoperability
           5.2.3 Market Opportunities
                    5.2.3.1 Emerging Markets for Healthcare It
                    5.2.3.2 Technological Advancements in Healthcare It Solutions
           5.2.4 Market Challenges
                    5.2.4.1 Integration of CDSS Solutions Within Healthcare Organizations
                    5.2.4.2 Lack of Skilled It Professionals in the Healthcare Industry
           5.2.5 US Regulatory Landscape: Clinical Decision Support Systems
                    5.2.5.1 Clinical Decision Support Systems and Meaningful use Requirements

6 Case Studies (Page No. - 54)
    6.1 Introduction
    6.2 Deployment of CDSS Resulted in the Early Detection of Hiv Patients
    6.3 Implementation of Cloud-Based Decision Support Platform Helped Reduce Sepsis Mortality Rate
    6.4 Reduction in the Number of Unnecessary Laboratory Tests at the Indiana Branch of the Veterans Health Administration After Using a Clinical Decision Support Tool
    6.5 Use of Clinical Decision Support Tool Helped Reduce Diagnostic Errors

7 Clinical Decision Support Systems Market, By Component (Page No. - 56)
    7.1 Introduction
    7.2 Services
    7.3 Software
    7.4 Hardware

8 Clinical Decision Support Systems Market, By Product (Page No. - 62)
    8.1 Introduction
    8.2 Integrated CDSS
    8.3 Standalone CDSS

9 Clinical Decision Support Systems Market, By Type (Page No. - 67)
    9.1 Introduction
    9.2 Therapeutic Clinical Decision Support Systems
    9.3 Diagnostic Clinical Decision Support Systems

10 Clinical Decision Support Systems Market, By Model (Page No. - 71)
     10.1 Introduction
     10.2 Knowledge-Based CDSS
     10.3 Non-Knowledge-Based CDSS

11 Clinical Decision Support Systems Market, By Delivery Mode (Page No. - 76)
     11.1 Introduction
     11.2 On-Premise CDSS
     11.3 Cloud-Based CDSS

12 Clinical Decision Support Systems Market, By Application (Page No. - 80)
     12.1 Introduction
     12.2 Conventional Clinical Decision Support Systems
     12.3 Advanced Clinical Decision Support Systems

13 Clinical Decision Support Systems Market, By Level of Interactivity (Page No. - 84)
     13.1 Introduction
     13.2 Active CDSS
     13.3 Passive CDSS

14 Clinical Decision Support Systems Market, By Setting (Page No. - 88)
     14.1 Introduction
     14.2 Inpatient Settings
     14.3 Ambulatory Care Settings

15 Global Clinical Decision Support Systems Market, By Region (Page No. - 92)
     15.1 Introduction
     15.2 North America
             15.2.1 US
             15.2.2 Canada
     15.3 Europe
             15.3.1 Germany
             15.3.2 UK
             15.3.3 France
             15.3.4 RoE
     15.4 Asia Pacific
     15.5 RoW

16 Competitive Landscape (Page No. - 146)
     16.1 Overview
     16.2 Ranking of Players and Industry Concentration, 2017
     16.3 Competitive Scenario
             16.3.1 Product Deployments, Enhancements, and Integrations
             16.3.2 Product Launches
             16.3.3 Agreements, Partnerships, Contracts, and Collaborations
             16.3.4 Acquisitions
             16.3.5 Expansions

17 Company Profiles (Page No. - 151)
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
     17.1 Cerner
     17.2 McKesson
     17.3 Epic Systems
     17.4 Meditech
     17.5 Philips Healthcare (A Subsidiary of Royal Philips Electronics)
     17.6 Wolters Kluwer Health
     17.7 Hearst Health
     17.8 Elsevier B.V. (A Division of Relx Group)
     17.9 IBM
     17.10 Allscripts Healthcare Solutions

*Details on Marketsandmarkets View, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments Might Not be Captured in Case of Unlisted Companies.

18 Appendix (Page No. - 189)
     18.1 Discussion Guide
     18.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
     18.3 Introducing Rt: Real-Time Market Intelligence
     18.4 Available Customizations
     18.5 Related Reports
     18.6 Author Details


List of Tables (114 Tables)

Table 1 Global Population Statistics, 2015 Vs. 2030 Vs. 2050 (Million Individuals)
Table 2 Clinical Decision Support Systems Market, By Component, 2016–2023 (USD Million)
Table 3 Clinical Decision Support Services Market, By Region, 2016–2023 (USD Million)
Table 4 Clinical Decision Support Software Market, By Region, 2016–2023 (USD Million)
Table 5 Clinical Decision Support Hardware Market, By Region, 2016–2023 (USD Million)
Table 6 Clinical Decision Support Systems Market, By Product, 2016–2023(USD Million)
Table 7 Integrated Clinical Decision Support Systems Market, By Region, 2016–2023(USD Million)
Table 8 Standalone Clinical Decision Support Systems Market, By Region, 2016–2023(USD Million)
Table 9 Clinical Decision Support Systems Market, By Type, 2016–2023 (USD Million)
Table 10 Therapeutic Clinical Decision Support Systems Market, By Region, 2016–2023 (USD Million)
Table 11 Diagnostic Clinical Decision Support Systems Market, By Region, 2016–2023 (USD Million)
Table 12 Clinical Decision Support Systems Market, By Model, 2016–2023 (USD Million)
Table 13 Knowledge-Based Clinical Decision Support Systems Market, By Region, 2016–2023 (USD Million)
Table 14 Non-Knowledge-Based Clinical Decision Support Systems Market, By Region, 2016–2023 (USD Million)
Table 15 Clinical Decision Support Systems Market, By Delivery Mode, 2016–2023 (USD Million)
Table 16 On-Premise Clinical Decision Support Systems Market, By Region, 2016–2023 (USD Million)
Table 17 Cloud-Based Clinical Decision Support Systems Market, By Region, 2016–2023 (USD Million)
Table 18 Clinical Decision Support Systems Market, By Application, 2016–2023 (USD Million)
Table 19 Conventional Clinical Decision Support Systems Market, By Region, 2016–2023 (USD Million)
Table 20 Advanced Clinical Decision Support Systems Market, By Region, 2016–2023 (USD Million)
Table 21 Clinical Decision Support Systems Market, By Level of Interactivity, 2016–2023 (USD Million)
Table 22 Active Clinical Decision Support Systems Market, By Region, 2016–2023 (USD Million)
Table 23 Passive Clinical Decision Support Systems Market, By Region, 2016–2023 (USD Million)
Table 24 Clinical Decision Support Systems Market, By Setting, 2016–2023 (USD Million)
Table 25 Clinical Decision Support Systems Market for Inpatient Settings, By Region, 2016–2023 (USD Million)
Table 26 Clinical Decision Support Systems Market for Ambulatory Care Settings, By Region, 2016–2023 (USD Million)
Table 27 Clinical Decision Support Systems Market, By Region, 2016–2023 (USD Million)
Table 28 North America: Clinical Decision Support Systems Market, By Country, 2016–20213 (USD Million)
Table 29 North America: Clinical Decision Support Systems Market, By Component, 2016–2023 (USD Million)
Table 30 North America: Clinical Decision Support Systems Market, By Delivery Mode, 2016–2023 (USD Million)
Table 31 North America: Clinical Decision Support Systems Market, By Product, 2016–2023 (USD Million)
Table 32 North America: Clinical Decision Support Systems Market, By Type, 2016–2023 (USD Million)
Table 33 North America: Clinical Decision Support Systems Market, By Model, 2016–2023 (USD Million)
Table 34 North America: Clinical Decision Support Systems Market, By Level of Interactivity, 2016–2023 (USD Million)
Table 35 North America: Clinical Decision Support Systems Market, By Application, 2016–2023 (USD Million)
Table 36 North America: Clinical Decision Support Systems Market, By Setting, 2016–2023 (USD Million)
Table 37 US: Clinical Decision Support Systems Market, By Component, 2016–2023 (USD Million)
Table 38 US: Clinical Decision Support Systems Market, By Delivery Mode, 2016–2023 (USD Million)
Table 39 US: Clinical Decision Support Systems Market, By Product, 2016–2023 (USD Million)
Table 40 US: Clinical Decision Support Systems Market, By Type, 2016–2023 (USD Million)
Table 41 US: Clinical Decision Support Systems Market, By Model, 2016–2023 (USD Million)
Table 42 US: Clinical Decision Support Systems Market, By Level of Interactivity, 2016–2023 (USD Million)
Table 43 US: Clinical Decision Support Systems Market, By Application, 2016–2023 (USD Million)
Table 44 US: Clinical Decision Support Systems Market, By Setting, 2016–2023 (USD Million)
Table 45 Canada: Clinical Decision Support Systems Market, By Component, 2016–2023 (USD Million)
Table 46 Canada: Clinical Decision Support Systems Market, By Delivery Mode, 2016–2023 (USD Million)
Table 47 Canada: Clinical Decision Support Systems Market, By Product, 2016–2023 (USD Million)
Table 48 Canada: Clinical Decision Support Systems Market, By Type, 2016–2023 (USD Million)
Table 49 Canada: Clinical Decision Support Systems Market, By Model, 2016–2023 (USD Million)
Table 50 Canada: Clinical Decision Support Systems Market, By Level of Interactivity, 2016–2023 (USD Million)
Table 51 Canada: Clinical Decision Support Systems Market, By Application, 2016–2023 (USD Million)
Table 52 Canada: Clinical Decision Support Systems Market, By Setting, 2016–2023 (USD Million)
Table 53 Europe: Clinical Decision Support Systems Market, By Country, 2016–2023 (USD Million)
Table 54 Europe: Clinical Decision Support Systems Market, By Component, 2016–2023 (USD Million)
Table 55 Europe: Clinical Decision Support Systems Market, By Delivery Mode, 2016–2023 (USD Million)
Table 56 Europe: Clinical Decision Support Systems Market, By Product, 2016–2023 (USD Million)
Table 57 Europe: Clinical Decision Support Systems Market, By Type, 2016–2023 (USD Million)
Table 58 Europe: Clinical Decision Support Systems Market, By Model, 2016–2023 (USD Million)
Table 59 Europe: Clinical Decision Support Systems Market, By Level of Interactivity, 2016–2023 (USD Million)
Table 60 Europe: Clinical Decision Support Systems Market, By Application, 2016–2023 (USD Million)
Table 61 Europe: Clinical Decision Support Systems Market, By Setting, 2016–2023 (USD Million)
Table 62 Germany: Clinical Decision Support Systems Market, By Component, 2016–2023 (USD Million)
Table 63 Germany: Clinical Decision Support Systems Market, By Delivery Mode, 2016–2023 (USD Million)
Table 64 Germany: Clinical Decision Support Systems Market, By Product, 2016–2023 (USD Million)
Table 65 Germany: Clinical Decision Support Systems Market, By Type, 2016–2023 (USD Million)
Table 66 Germany: Clinical Decision Support Systems Market, By Model, 2016–2023 (USD Million)
Table 67 Germany: Clinical Decision Support Systems Market, By Level of Interactivity, 2016–2023 (USD Million)
Table 68 Germany: Clinical Decision Support Systems Market, By Application, 2016–2023 (USD Million)
Table 69 Germany: Clinical Decision Support Systems Market, By Setting, 2016–2023 (USD Million)
Table 70 UK: Clinical Decision Support Systems Market, By Component, 2016–2023 (USD Million)
Table 71 UK: Clinical Decision Support Systems Market, By Delivery Mode, 2016–2023 (USD Million)
Table 72 UK: Clinical Decision Support Systems Market, By Product, 2016–2023 (USD Million)
Table 73 UK: Clinical Decision Support Systems Market, By Type, 2016–2023 (USD Million)
Table 74 UK: Clinical Decision Support Systems Market, By Model, 2016–2023 (USD Million)
Table 75 UK: Clinical Decision Support Systems Market, By Level of Interactivity, 2016–2023 USD Million)
Table 76 UK: Clinical Decision Support Systems Market, By Application, 2016–2023 (USD Million)
Table 77 UK: Clinical Decision Support Systems Market, By Setting, 2016–2023 (USD Million)
Table 78 France: Clinical Decision Support Systems Market, By Component, 2016–2023 (USD Million)
Table 79 France: Clinical Decision Support Systems Market, By Delivery Mode, 2016–2023 (USD Million)
Table 80 France: Clinical Decision Support Systems Market, By Product, 2016–2023 (USD Million)
Table 81 France: Clinical Decision Support Systems Market, By Type, 2016–2023 (USD Million)
Table 82 France: Clinical Decision Support Systems Market, By Model, 2016–2023 (USD Million)
Table 83 France: Clinical Decision Support Systems Market, By Level of Interactivity, 2016–2023 (USD Million)
Table 84 France: Clinical Decision Support Systems Market, By Application, 2016–2023 (USD Million)
Table 85 France: Clinical Decision Support Systems Market, By Setting, 2016–2023 (USD Million)
Table 86 RoE: Clinical Decision Support Systems Market, By Component, 2016–2023 (USD Million)
Table 87 RoE: Clinical Decision Support Systems Market, By Delivery Mode, 2016–2023 (USD Million)
Table 88 RoE: Clinical Decision Support Systems Market, By Product, 2016–2023 (USD Million)
Table 89 RoE: Clinical Decision Support Systems Market, By Type, 2016–2023 (USD Million)
Table 90 RoE: Clinical Decision Support Systems Market, By Model, 2016–2023 (USD Million)
Table 91 RoE: Clinical Decision Support Systems Market, By Level of Interactivity, 2016–2023 (USD Million)
Table 92 RoE: Clinical Decision Support Systems Market, By Application, 2016–2023 (USD Million)
Table 93 RoE: Clinical Decision Support Systems Market, By Setting, 2016–2023 (USD Million)
Table 94 APAC: Clinical Decision Support Systems Market, By Component, 2016–2023 (USD Million)
Table 95 APAC: Clinical Decision Support Systems Market, By Delivery Mode, 2016–2023 (USD Million)
Table 96 APAC: Clinical Decision Support Systems Market, By Product, 2016–2023 (USD Million)
Table 97 APAC: Clinical Decision Support Systems Market, By Type, 2016–2023 (USD Million)
Table 98 APAC: Clinical Decision Support Systems Market, By Model, 2016–2023 (USD Million)
Table 99 APAC: Clinical Decision Support Systems Market, By Level of Interactivity, 2016–2023 (USD Million)
Table 100 APAC: Clinical Decision Support Systems Market, By Application, 2016–2023 (USD Million)
Table 101 APAC: Clinical Decision Support Systems Market, By Setting, 2016–2023 (USD Million)
Table 102 RoW: Clinical Decision Support Systems Market, By Component, 2016–2023 (USD Million)
Table 103 RoW: Clinical Decision Support Systems Market, By Delivery Mode, 2016–2023 (USD Million)
Table 104 RoW: Clinical Decision Support Systems Market, By Product, 2016–2023 (USD Million)
Table 105 RoW: Clinical Decision Support Systems Market, By Type, 2016–2023 (USD Million)
Table 106 RoW: Clinical Decision Support Systems Market, By Model, 2016–2023 (USD Million)
Table 107 RoW: Clinical Decision Support Systems Market, By Level of Interactivity, 2016–2023 (USD Million)
Table 108 RoW: Clinical Decision Support Systems Market, By Application, 2016–2023 (USD Million)
Table 109 RoW: Clinical Decision Support Systems Market, By Setting, 2016–2023 (USD Million)
Table 110 Wolters Kluwer Led the Clinical Decision Support Systems Market in 2017
Table 111 Product Deployments (2014–2018)
Table 112 Product Launches (2014–2018)
Table 113 Agreements, Partnerships, Contracts, and Collaborations (2014–2018)
Table 114 Acquisitions (2014–2018)
 
 
List of Figures (36 Figures)
 
Figure 1 Research Methodology: Global CDSS Market
Figure 2 Research Design
Figure 3 Sampling Frame: Primary Research
Figure 4 Market Size Estimation Methodology: Bottom-Up Approach
Figure 5 Market Size Estimation Methodology: Top-Down Approach
Figure 6 Data Triangulation Methodology
Figure 7 The Services Segment Dominated the Clinical Decision Support Systems Market, By Component, in 2017
Figure 8 On-Premise CDSS Accounted for the Larger Share of the Clinical Decision Support Systems Market, By Delivery Mode, in 2017
Figure 9 Integrated CDSS to Account for the Largest Share of the Clinical Decision Support Systems Market, By Product, in 2018
Figure 10 Conventional CDSS to Continue to Dominate the Clinical Decision Support Systems Market, By Application, in 2023
Figure 11 Knowledge-Based CDSS Accounted for the Largest Share of the Clinical Decision Support Systems Market, By Model, in 2017
Figure 12 Active CDSS to Account for the Largest Share of the Market, By Level of Interactivity, During the Forecast Period
Figure 13 Therapeutic CDSS Commanded the Larger Share of the Market, By Type, in 2017
Figure 14 Inpatient Settings to Dominate the CDSS Market, By Setting, During the Forecast Period
Figure 15 Asia Pacific to Witness the Highest Market Growth During the Forecast Period
Figure 16 Government Initiatives to Drive the Adoption of CDSS Solutions During the Forecast Period
Figure 17 Knowledge-Based Clinical Decision Support Systems to Dominate the Clinical Decision Support Systems Market, By Model, in 2018
Figure 18 Active Clinical Decision Support Systems to Dominate the Clinical Decision Support Systems Market, By Level of Interactivity, in 2018
Figure 19 Advanced CDSS Segment Commands the Largest Share of the Clinical Decision Support Systems Market, By Application, in 2018
Figure 20 Asia Pacific to Witness the Highest Growth Rate During the Forecast Period
Figure 21 Clinical Decision Support Systems Market: Drivers, Restraints, Opportunities, and Challenges
Figure 22 Inpatient Settings Accounted for Largest Share of the CDSS Market
Figure 23 Clinical Decision Support Systems Market, By Region, 2017
Figure 24 North America: Market Snapshot
Figure 25 Europe: Market Snapshot
Figure 26 Asia Pacific: Market Snapshot
Figure 27 RoW: Market Snapshot
Figure 28 Key Developments in the Clinical Decision Support Systems Market Between 2014 and 2018
Figure 29 Cerner: Company Snapshot
Figure 30 McKesson: Company Snapshot
Figure 31 Meditech: Company Snapshot
Figure 32 Philips: Company Snapshot
Figure 33 Wolters Kluwer: Company Snapshot
Figure 34 Relx Group: Company Snapshot
Figure 35 IBM: Company Snapshot
Figure 36 Allscripts Healthcare Solutions: Company Snapshot


Request for detailed methodology, assumptions & how numbers were triangulated.

Please share your problem/objectives in greater details so that our analyst can verify if they can solve your problem(s).
4 0 0 7 7  
  • Select all
  • News-Letters with latest Market insights
  • Information & discussion on the relevant new products and services
  • Information & discussion on Market insights and Market information
  • Information & discussion on our events and conferences
    • Select all
    • Email Phone Professional and social network (Linkedin, etc)
COVID-19

Get in-depth analysis of the COVID-19 impact on the Clinical Decision Support Systems Market

Benchmarking the rapid strategy shifts of the Top 100 companies in the Clinical Decision Support Systems Market

Request For Special Pricing
Report Code
HIT 2237
Published ON
Mar, 2018
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Clinical Decision Support Systems Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2020 MarketsandMarkets Research Private Ltd. All rights reserved
...

Digital Virtual Assistant - MarketsandMarkets

Home